Dr. Ashay Karpe | Transformational Leadership |Best researcher Award

Congratulations, Dr. Ashay Karpe  | Best Researcher Award  | Winner 2023

Dr. Ashay Karpe : Transformational Leadership

Congratulations Dr. Ashay Karpe on Winning Best Researcher Award! Dear Dr. Karpe, Heartiest congratulations on receiving the Best Researcher Award for your outstanding work in Transformational Leadership! Your dedication, innovation, and commitment to advancing knowledge have truly set you apart.

Early Academic Pursuits:

Dr. Ashay Pramod Karpe embarked on his academic journey at Seth G. S. Medical College, K. E. M. Hospital, Mumbai, where he earned his M.B.B.S. degree in the period of September 1996 to January 2002. Demonstrating exceptional academic prowess, he continued his studies at Govt. Medical College & Hospital, Aurangabad, securing the Gold Medal in M.D. (General Medicine) in March 2007.

Professional Endeavors:

Dr. Karpe's commitment to medical excellence led him to pursue a D.M. (Medical Oncology) at Tata Memorial Hospital, Mumbai, where he emerged as the Gold Medallist of the 2012 batch. Subsequently, he further honed his expertise as a Fellow in Clinical Haematology at Tata Medical Center, Kolkata, playing a pivotal role in establishing a Stem Cell Transplant unit.

His dedication continued as a Sp. Registrar (Clinical Haematology) at Sahyadri Speciality Hospital, Pune, from June 2007 to November 2010. During this time, he gained extensive experience in both clinical and laboratory haematology, conducting various Stem Cell Transplants.

Contributions and Research Focus:

Dr. Karpe's research focus spans solid tumors, hematological malignancies, and stem cell transplant. His contributions include managing recurrent oral cancers, exploring metronomic palliative chemotherapy, and addressing rare congenital bleeding disorders. Notably, his involvement as Co-principal Investigator in clinical trials like VANTAGE 088 underscores his commitment to advancing medical knowledge.

Accolades and Recognition:

Dr. Ashay Pramod Karpe's exemplary achievements have been consistently acknowledged through prestigious awards, including the Outstanding Student Award by HBNI in 2015, the DNB President's Gold Medal in December 2015, and Gold Medals in both DM (Medical Oncology) and MD (General Medicine).

Impact and Influence:

As a practicing consultant in Medical Oncology and Hematology since August 2016, Dr. Karpe has made a significant impact on patient care. Serving as the Director of Sunrise Oncology Care and President of the Cancer Research & Statistics Foundation, he continues to shape the landscape of oncology.

Legacy and Future Contributions:

Dr. Karpe's legacy lies in his commitment to advancing cancer research, patient care, and medical education. His comprehensive approach to oncology, from clinical practice to research and leadership roles, positions him as a leader in the field. The future holds the promise of further contributions and advancements under his guidance.

Notable Publications

Technically unresectable recurrent oral cancers: Is NACT the answer? - Vijay M. Patil, Amit Joshi, Vanita
Noronha, Ashay Karpe, Shashikant Juvekar, Pankaj Chaturvedi, Prathamesh Pai, Anil D‘Cruz, Kumar Prabhash.
Oral Oncology -May 2016 May;56:e12-4. doi: 10.1016 j.oraloncology.2016.03.015. Epub 2016 Mar 31.
2. Metronomic palliative chemotherapy in maxillary sinus tumor :- Vijay M Patil, Vanita Noronha, Amit Joshi, Ashay
Karpe, Kumar Prabhash, South Asian Journal of Cancer-2016 (Vol 5) Issue 2;P- 56-58
3. Rare Congenital Bleeding Disorders from a Tertiary Haematology Referral Center in Western India. Anjali Kelkar,
Shashikant Apte, Ashay Karpe. Blood (ASH Annual Meeting Abstracts), Nov 2008; 112: 4519
4. Oral TKI in Poor PS Lung Cancer Patients :P131-F004 S.Jandyal, A.Karpe, V.Patil, V.Noronha, A.Joshi,
K.Prabhash. European Journal of Cancer 54,Suppl.1(2016)S29
5. Efficacy of second line Erlotinib in patients post progression of first line therapy in Head and Neck cancers:
P227D019. V.Patil, A.Joshi,A.Karpe,V.Noronha, K.Prabhash. European Journal of Cancer 54,Suppl.1(2016)S24
6. Frequency of bacterial isolates and pattern of antimicrobial resistance in patients with hematological malignancies:
A snapshot from tertiary cancer center. M Sengar, R Kelkar, H Jain A Karpe. Indian Journal of Cancer-2014 (51)-
Issue4;P-456-458